BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 33464483)

  • 1. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
    Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
    Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells.
    Ono M; Oka S; Okudaira H; Nakanishi T; Mizokami A; Kobayashi M; Schuster DM; Goodman MM; Shirakami Y; Kawai K
    Nucl Med Biol; 2015 Nov; 42(11):887-92. PubMed ID: 26278491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.
    Dondoo TO; Fukumori T; Daizumoto K; Fukawa T; Kohzuki M; Kowada M; Kusuhara Y; Mori H; Nakatsuji H; Takahashi M; Kanayama HO
    Anticancer Res; 2017 Jan; 37(1):125-134. PubMed ID: 28011482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.
    Okudaira H; Oka S; Ono M; Nakanishi T; Schuster DM; Kobayashi M; Goodman MM; Tamai I; Kawai K; Shirakami Y
    Mol Imaging Biol; 2014 Dec; 16(6):756-64. PubMed ID: 24943499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
    Vaz CV; Marques R; Alves MG; Oliveira PF; Cavaco JE; Maia CJ; Socorro S
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):5-16. PubMed ID: 26048031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.
    Lin TH; Lee SO; Niu Y; Xu D; Liang L; Li L; Yeh SD; Fujimoto N; Yeh S; Chang C
    J Biol Chem; 2013 Jul; 288(27):19359-69. PubMed ID: 23687298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.
    Thomas C; Wafa LA; Lamoureux F; Cheng H; Fazli L; Gleave ME; Rennie PS
    Prostate; 2012 Jun; 72(8):875-85. PubMed ID: 22072572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells.
    Lu S; Wang A; Lu S; Dong Z
    Mol Cancer Ther; 2007 Jul; 6(7):2057-64. PubMed ID: 17620434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
    Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y
    BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells.
    He J; Lan X; Duan HL; Luo H; Zhou XD
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrotestosterone enhances castration-resistant prostate cancer cell proliferation through STAT5 activation via glucocorticoid receptor pathway.
    Song C; Kim Y; Min GE; Ahn H
    Prostate; 2014 Sep; 74(12):1240-8. PubMed ID: 25043756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgens regulate Hedgehog signalling and proliferation in androgen-dependent prostate cells.
    Sirab N; Terry S; Giton F; Caradec J; Chimingqi M; Moutereau S; Vacherot F; de la Taille A; Kouyoumdjian JC; Loric S
    Int J Cancer; 2012 Sep; 131(6):1297-306. PubMed ID: 22131072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2.
    Feng S; Tang Q; Sun M; Chun JY; Evans CP; Gao AC
    Mol Cancer Ther; 2009 Mar; 8(3):665-71. PubMed ID: 19240160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer.
    Jones D; Wade M; Nakjang S; Chaytor L; Grey J; Robson CN; Gaughan L
    Oncotarget; 2015 Oct; 6(30):29782-94. PubMed ID: 26336819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell lines.
    Argellati F; Nuzzo PV; Ricci F; Mangerini R; Rubagotti A; Boccardo F
    Anticancer Res; 2013 Mar; 33(3):815-20. PubMed ID: 23482749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and migration of LNCaP prostate cancer cells are promoted by triclosan and benzophenone-1 via an androgen receptor signaling pathway.
    Kim SH; Hwang KA; Shim SM; Choi KC
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):568-76. PubMed ID: 25682003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
    Jang YG; Go RE; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
    Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.